高级搜索
肺低剂量区体积预测胸中下段食管癌放射性肺炎的价值[J]. 肿瘤防治研究, 2015, 42(01): 32-36. DOI: 10.3971/j.issn.1000-8578.2015.01.008
引用本文: 肺低剂量区体积预测胸中下段食管癌放射性肺炎的价值[J]. 肿瘤防治研究, 2015, 42(01): 32-36. DOI: 10.3971/j.issn.1000-8578.2015.01.008
null[J]. Cancer Research on Prevention and Treatment, 2015, 42(01): 32-36. DOI: 10.3971/j.issn.1000-8578.2015.01.008
Citation: null[J]. Cancer Research on Prevention and Treatment, 2015, 42(01): 32-36. DOI: 10.3971/j.issn.1000-8578.2015.01.008

肺低剂量区体积预测胸中下段食管癌放射性肺炎的价值

null

  • 摘要: 目的 明确肺低剂量区体积在预测接受放射治疗的胸中下段食管癌患者出现急性放射性肺炎(radiation pneumonitis, RP)的价值。方法 对205例接受放射治疗并符合入组条件的胸中下段食管癌患者发生RP的情况进行分析,对患者临床资料和治疗计划等指标进行单因素及多因素分析,评价肺低剂量区体积指标的价值。结果 全组患者出现≥2级RP的患者为60例占29.27%(60/205),其中2级48例(23.41%),3级10例(4.88%),4级2例(0.98%)。单因素分析结果显示食管癌病变X 线长度、GTV最大横径、GTV长度、射野数、肺MLD、GTV体积、PTV体积、肺V5、肺V10和肺V15均影响患者≥2级RP的发生。多因素分析结果显示射野数、肺MLD及肺V5为患者≥2级RP发生的独立预测影响因素。ROC曲线分析结果显示本组患者肺V5取值为51.17%为预测放射性肺炎的效能值。结论 肺低剂量区体积V5为接受放疗的胸中下段食管癌患者发生≥2级RP的重要预测因素,建议在以后制定胸中下段食管癌的放射治疗计划时应该予以重视,取值应≤51.17%。

     

    Abstract: Objective To clear and definite the predictive value of low dose volume of lung on acute radiation pneumonitis(RP) in patients with middle and lower thoracic esophageal cancer. Methods Two hundred and five patients with middle and lower thoracic esophageal cancer treated with radiotherapy were followed up. The clinical factors and treatment parameters were analyzed by univariate and multivariate analysis. Indexes of low dose volume of lung were evaluated. Results The acute RP with ≥grade 2 were observed in 60 patients(29.27%, 60/205). The incidence of grade 2, 3 and 4 were 23.41%(48/205), 4.88%(10/205) and 0.98%(2/205), respectively. Univariate analysis showed that the X-ray length of esophagus cancer lesion,the maximum transverse diameter of GTV, GTV length, radiation fields, MLD, GTV volume, PTV volume and lung V5-V15 all had significant relationship with ≥grade 2 acute RP. Multivariate analysis showed that radiation fields, MLD and Lung V5 were the independent risk factors for ≥grade 2 acute RP. ROC curves showed that the efficiency value to predict RP for V5 values was 51.17%. Conclusion The low dose volume of V5 is effective in predicting ≥grade 2 acute RP in patients with middle and lower thoracic esophageal cancer. We recommend that it should be attached importance in the radiotherapy plan for middle and lower esophageal cancer in the future and the effective value should be ≤51.17%.

     

/

返回文章
返回